New Delhi, March 31 Novo Nordisk India announced on Tuesday reductions in the prices of Ozempic and Wegovy in India, days after the launch of generic versions of semaglutide injections for patients with type 2 diabetes and obesity.Indian pharmaceutical companies recently announced the launch...
cardiometabolic health
clinical evidence
diabetes
drug pricing
generic drugs
healthcare costs
india
novo nordisk
obesity
ozempic
pharmaceuticals
semaglutide
treatment
type 2 diabetes
wegovy
New Delhi, March 21 Pharmaceutical companies Torrent Pharmaceuticals, Alkem Laboratories, and USV Ltd. launched Semaglutide-based generic diabetes treatment medication in the country on Saturday.Torrent Pharma launched its Semaglutide brands, Sembolic and Semalix, in both oral and injectable...
New Delhi, March 21 Indian pharmaceutical companies Sun Pharma, Dr Reddy's, and Glenmark announced on Saturday the launch of their generic versions of semaglutide injection, used for diabetes and weight management, following the expiration of patents on products like Ozempic and Wegovy in India...